| Basics |
Seres Therapeutics, Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.
|
| IPO Date: |
June 26, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$63.14M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.37 | 3.68%
|
| Avg Daily Range (30 D): |
$0.41 | 6.16%
|
| Avg Daily Range (90 D): |
$0.17 | 4.75%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.07M |
| Avg Daily Volume (30 D): |
.36M |
| Avg Daily Volume (90 D): |
.75M |
| Trade Size |
| Avg Trade Size (Sh.): |
173 |
| Avg Trade Size (Sh.) (30 D): |
273 |
| Avg Trade Size (Sh.) (90 D): |
392 |
| Institutional Trades |
| Total Inst.Trades: |
1,288 |
| Avg Inst. Trade: |
$1.89M |
| Avg Inst. Trade (30 D): |
$.76M |
| Avg Inst. Trade (90 D): |
$.76M |
| Avg Inst. Trade Volume: |
.2M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.21M |
| Avg Closing Trade (30 D): |
$.6M |
| Avg Closing Trade (90 D): |
$.6M |
| Avg Closing Volume: |
251.79K |
|
|
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$4.01
|
$3.76
|
$-.11
|
|
Diluted EPS
|
$4
|
$3.75
|
$-.11
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ 72.95M
|
$ 32.68M
|
$ -15.64M
|
|
Operating Income / Loss
|
$ -116.59M
|
$ -27.24M
|
$ -28.84M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -52.1M
|
$ 28.06M
|
$ -37.24M
|
|
PE Ratio
|
1.74
|
|
|
| Splits |
|
Apr 22, 2025:
1:20
|
|
